

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative T cell selection (GO:0043383) | 9.82869866 |
| 2 | negative thymic T cell selection (GO:0045060) | 9.19304156 |
| 3 | regulation of isotype switching to IgG isotypes (GO:0048302) | 8.41772167 |
| 4 | negative regulation of cell killing (GO:0031342) | 7.72831520 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.72831520 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.65639513 |
| 7 | thymic T cell selection (GO:0045061) | 7.39677637 |
| 8 | positive T cell selection (GO:0043368) | 7.24350037 |
| 9 | cytidine deamination (GO:0009972) | 7.14232513 |
| 10 | cytidine metabolic process (GO:0046087) | 7.14232513 |
| 11 | cytidine catabolic process (GO:0006216) | 7.14232513 |
| 12 | positive thymic T cell selection (GO:0045059) | 7.08858303 |
| 13 | T cell migration (GO:0072678) | 7.08574871 |
| 14 | T cell selection (GO:0045058) | 6.98086766 |
| 15 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.84880243 |
| 16 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 6.66985188 |
| 17 | DNA deamination (GO:0045006) | 6.50384783 |
| 18 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.42065412 |
| 19 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.19442713 |
| 20 | positive regulation of B cell differentiation (GO:0045579) | 6.18008092 |
| 21 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.17058578 |
| 22 | response to interleukin-15 (GO:0070672) | 6.14726107 |
| 23 | interferon-gamma production (GO:0032609) | 5.72967063 |
| 24 | T cell receptor signaling pathway (GO:0050852) | 5.62822130 |
| 25 | cellular response to interleukin-15 (GO:0071350) | 5.53873868 |
| 26 | regulation of gamma-delta T cell activation (GO:0046643) | 5.52220254 |
| 27 | regulation of activation of Janus kinase activity (GO:0010533) | 5.48969242 |
| 28 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 5.45102895 |
| 29 | positive regulation of isotype switching (GO:0045830) | 5.43972137 |
| 30 | regulation of alpha-beta T cell proliferation (GO:0046640) | 5.32074937 |
| 31 | regulation of T cell tolerance induction (GO:0002664) | 5.17034677 |
| 32 | T cell costimulation (GO:0031295) | 5.10507332 |
| 33 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.02570427 |
| 34 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.02570427 |
| 35 | lymphocyte costimulation (GO:0031294) | 5.00965814 |
| 36 | actin nucleation (GO:0045010) | 4.97939938 |
| 37 | negative regulation of T cell apoptotic process (GO:0070233) | 4.94467516 |
| 38 | activated T cell proliferation (GO:0050798) | 4.86385757 |
| 39 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.83223384 |
| 40 | positive regulation of B cell mediated immunity (GO:0002714) | 4.78847136 |
| 41 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 4.78847136 |
| 42 | regulation of B cell differentiation (GO:0045577) | 4.76227305 |
| 43 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.69524182 |
| 44 | negative regulation by host of viral transcription (GO:0043922) | 4.68809715 |
| 45 | positive regulation of DNA recombination (GO:0045911) | 4.67837369 |
| 46 | mast cell activation (GO:0045576) | 4.60392378 |
| 47 | heterotypic cell-cell adhesion (GO:0034113) | 4.59752446 |
| 48 | ribosomal small subunit assembly (GO:0000028) | 4.53589324 |
| 49 | leukocyte aggregation (GO:0070486) | 4.51970647 |
| 50 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.51885445 |
| 51 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 4.49194215 |
| 52 | positive regulation of humoral immune response (GO:0002922) | 4.47114902 |
| 53 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.45913911 |
| 54 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.45913911 |
| 55 | eosinophil chemotaxis (GO:0048245) | 4.40496196 |
| 56 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.37873870 |
| 57 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.34520127 |
| 58 | regulation of isotype switching (GO:0045191) | 4.32160658 |
| 59 | negative regulation of T cell mediated immunity (GO:0002710) | 4.31359574 |
| 60 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.24714159 |
| 61 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.24714159 |
| 62 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.19543692 |
| 63 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.19008547 |
| 64 | lymphocyte migration (GO:0072676) | 4.18837122 |
| 65 | positive regulation of tolerance induction (GO:0002645) | 4.14976529 |
| 66 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.12855016 |
| 67 | positive regulation of immunoglobulin production (GO:0002639) | 4.10609275 |
| 68 | regulation of chronic inflammatory response (GO:0002676) | 4.07233272 |
| 69 | megakaryocyte development (GO:0035855) | 4.05072722 |
| 70 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.03451821 |
| 71 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.01053749 |
| 72 | eosinophil migration (GO:0072677) | 3.99717227 |
| 73 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.99423751 |
| 74 | positive regulation of interleukin-2 production (GO:0032743) | 3.98741695 |
| 75 | chaperone-mediated protein transport (GO:0072321) | 3.97342077 |
| 76 | signal complex assembly (GO:0007172) | 3.97319616 |
| 77 | T cell differentiation (GO:0030217) | 3.92399540 |
| 78 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.87853992 |
| 79 | regulation of B cell mediated immunity (GO:0002712) | 3.85245399 |
| 80 | monocyte chemotaxis (GO:0002548) | 3.83580571 |
| 81 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.83170422 |
| 82 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.78315577 |
| 83 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.77834432 |
| 84 | leukocyte cell-cell adhesion (GO:0007159) | 3.73484308 |
| 85 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.69245663 |
| 86 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.68567542 |
| 87 | SMAD protein complex assembly (GO:0007183) | 3.68177523 |
| 88 | regulation of regulatory T cell differentiation (GO:0045589) | 3.65498214 |
| 89 | natural killer cell differentiation (GO:0001779) | 3.61610504 |
| 90 | regulation of tolerance induction (GO:0002643) | 3.60603525 |
| 91 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.60277282 |
| 92 | Peyers patch development (GO:0048541) | 3.56537961 |
| 93 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.56537961 |
| 94 | positive regulation of T cell apoptotic process (GO:0070234) | 3.55519851 |
| 95 | alpha-beta T cell activation (GO:0046631) | 3.55472734 |
| 96 | T cell activation (GO:0042110) | 3.55075210 |
| 97 | regulation of immunoglobulin production (GO:0002637) | 3.53289848 |
| 98 | sequestering of actin monomers (GO:0042989) | 3.53014813 |
| 99 | alpha-beta T cell differentiation (GO:0046632) | 3.50992395 |
| 100 | mast cell activation involved in immune response (GO:0002279) | 3.50153499 |
| 101 | mast cell degranulation (GO:0043303) | 3.50153499 |
| 102 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.49659747 |
| 103 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.47934708 |
| 104 | peroxisome fission (GO:0016559) | 3.47687679 |
| 105 | T cell proliferation (GO:0042098) | 3.46817375 |
| 106 | deoxyribose phosphate catabolic process (GO:0046386) | 3.43865339 |
| 107 | positive regulation of cell killing (GO:0031343) | 3.43796384 |
| 108 | deoxyribonucleotide catabolic process (GO:0009264) | 3.38993445 |
| 109 | V(D)J recombination (GO:0033151) | 3.37641538 |
| 110 | regulation of T cell apoptotic process (GO:0070232) | 3.36174921 |
| 111 | negative regulation of B cell proliferation (GO:0030889) | 3.34219037 |
| 112 | regulation of cell killing (GO:0031341) | 3.33061226 |
| 113 | negative regulation of viral genome replication (GO:0045071) | 3.32791704 |
| 114 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.32470388 |
| 115 | positive regulation of T cell chemotaxis (GO:0010820) | 3.31720010 |
| 116 | regulation of T cell chemotaxis (GO:0010819) | 3.31720010 |
| 117 | regulation of defense response to virus by virus (GO:0050690) | 3.31625845 |
| 118 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.31137911 |
| 119 | positive regulation of interleukin-17 production (GO:0032740) | 3.23009491 |
| 120 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.22485656 |
| 121 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.20308088 |
| 122 | dendritic cell chemotaxis (GO:0002407) | 3.17978305 |
| 123 | macrophage chemotaxis (GO:0048246) | 3.15862390 |
| 124 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.15749732 |
| 125 | immunoglobulin mediated immune response (GO:0016064) | 3.14457095 |
| 126 | B cell receptor signaling pathway (GO:0050853) | 3.14418179 |
| 127 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 3.13619605 |
| 128 | cellular response to interleukin-4 (GO:0071353) | 3.12609435 |
| 129 | base-excision repair, AP site formation (GO:0006285) | 3.12218881 |
| 130 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.11684181 |
| 131 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.09249735 |
| 132 | positive regulation of gluconeogenesis (GO:0045722) | 3.08820183 |
| 133 | regulation of macrophage chemotaxis (GO:0010758) | 3.08592261 |
| 134 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.08477283 |
| 135 | regulation of response to tumor cell (GO:0002834) | 3.07769847 |
| 136 | positive regulation of response to tumor cell (GO:0002836) | 3.07769847 |
| 137 | positive regulation of immune response to tumor cell (GO:0002839) | 3.07769847 |
| 138 | regulation of immune response to tumor cell (GO:0002837) | 3.07769847 |
| 139 | leukocyte tethering or rolling (GO:0050901) | 3.07717357 |
| 140 | regulation of calcium-mediated signaling (GO:0050848) | 3.06060030 |
| 141 | positive regulation of defense response to virus by host (GO:0002230) | 3.03584070 |
| 142 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.02073019 |
| 143 | cellular defense response (GO:0006968) | 3.00330685 |
| 144 | T cell homeostasis (GO:0043029) | 3.00036471 |
| 145 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.97868990 |
| 146 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.97816957 |
| 147 | negative regulation of B cell apoptotic process (GO:0002903) | 2.97072028 |
| 148 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.95951851 |
| 149 | regulation of interleukin-2 production (GO:0032663) | 2.94879346 |
| 150 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.94368915 |
| 151 | regulation of lymphocyte mediated immunity (GO:0002706) | 2.92180147 |
| 152 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.89429944 |
| 153 | positive regulation of lymphocyte migration (GO:2000403) | 2.89207903 |
| 154 | regulation of mononuclear cell migration (GO:0071675) | 2.87739203 |
| 155 | negative regulation of leukocyte apoptotic process (GO:2000107) | 2.87454491 |
| 156 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.84506088 |
| 157 | regulation of monocyte chemotaxis (GO:0090025) | 2.82950619 |
| 158 | DNA dealkylation (GO:0035510) | 2.82419549 |
| 159 | DNA demethylation (GO:0080111) | 2.82191274 |
| 160 | positive regulation of translational initiation (GO:0045948) | 2.81472112 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 9.27817533 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 7.33743912 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.91285932 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.35823667 |
| 5 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.16647847 |
| 6 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.88597636 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 3.75168439 |
| 8 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.65719166 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.64780463 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.62080700 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.42213516 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.29946891 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.28327547 |
| 14 | MYB_26560356_Chip-Seq_TH2_Human | 3.22934346 |
| 15 | MAF_26560356_Chip-Seq_TH1_Human | 2.82281688 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.81510951 |
| 17 | UTX_26944678_Chip-Seq_JUKART_Human | 2.60550430 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.57358040 |
| 19 | MYB_26560356_Chip-Seq_TH1_Human | 2.51974435 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.44850789 |
| 21 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.36003378 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.12358763 |
| 23 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.02961384 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01197403 |
| 25 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.00190462 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.96144790 |
| 27 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.96036940 |
| 28 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.89997265 |
| 29 | MAF_26560356_Chip-Seq_TH2_Human | 1.84555946 |
| 30 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.83911402 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.79723704 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.77904553 |
| 33 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.77763783 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.76361166 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.71196324 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.65764231 |
| 37 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.64105829 |
| 38 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.63858487 |
| 39 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.62994144 |
| 40 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.60321495 |
| 41 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.60062248 |
| 42 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.58233284 |
| 43 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.55464203 |
| 44 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.53778521 |
| 45 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.53481195 |
| 46 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.52773996 |
| 47 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.50483500 |
| 48 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.46522912 |
| 49 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.45415976 |
| 50 | VDR_22108803_ChIP-Seq_LS180_Human | 1.45296609 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43823060 |
| 52 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.43736962 |
| 53 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.42350994 |
| 54 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.40613014 |
| 55 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.38312282 |
| 56 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.34431548 |
| 57 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34031205 |
| 58 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.32399009 |
| 59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31853287 |
| 60 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.31680058 |
| 61 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.27647628 |
| 62 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.26953524 |
| 63 | P300_27268052_Chip-Seq_Bcells_Human | 1.25013305 |
| 64 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20829786 |
| 65 | SPI1_23127762_ChIP-Seq_K562_Human | 1.15469394 |
| 66 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.15091493 |
| 67 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.14658827 |
| 68 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.14572733 |
| 69 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.14056367 |
| 70 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12301220 |
| 71 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.12178675 |
| 72 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.11863275 |
| 73 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11117297 |
| 74 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.10617054 |
| 75 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.09784277 |
| 76 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.07098740 |
| 77 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.04858012 |
| 78 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03520209 |
| 79 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.02816330 |
| 80 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02517789 |
| 81 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.99371713 |
| 82 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.99123275 |
| 83 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.98790767 |
| 84 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.98754198 |
| 85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98337302 |
| 86 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.96344804 |
| 87 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95401415 |
| 88 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.95380057 |
| 89 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.95360830 |
| 90 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.95317396 |
| 91 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.95147449 |
| 92 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.94283291 |
| 93 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.94089554 |
| 94 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92583635 |
| 95 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92468476 |
| 96 | GATA1_22025678_ChIP-Seq_K562_Human | 0.92276436 |
| 97 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.91918308 |
| 98 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90960706 |
| 99 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.90379124 |
| 100 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.87038004 |
| 101 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.86256014 |
| 102 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85727439 |
| 103 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.85570526 |
| 104 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.85549410 |
| 105 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.84686046 |
| 106 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84355847 |
| 107 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84207795 |
| 108 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.83898707 |
| 109 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.83303585 |
| 110 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.82397312 |
| 111 | P68_20966046_ChIP-Seq_HELA_Human | 0.81883306 |
| 112 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81383902 |
| 113 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.81006639 |
| 114 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79967408 |
| 115 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.79043970 |
| 116 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.78812638 |
| 117 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78292381 |
| 118 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.78080927 |
| 119 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.77070694 |
| 120 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76920057 |
| 121 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.76536787 |
| 122 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.76272439 |
| 123 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76060582 |
| 124 | GATA3_26560356_Chip-Seq_TH1_Human | 0.75800578 |
| 125 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.75706366 |
| 126 | SA1_27219007_Chip-Seq_Bcells_Human | 0.74859384 |
| 127 | GATA2_19941826_ChIP-Seq_K562_Human | 0.74842971 |
| 128 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.74065214 |
| 129 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.74042986 |
| 130 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73441989 |
| 131 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.71548558 |
| 132 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.70867878 |
| 133 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.70453509 |
| 134 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.69425815 |
| 135 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.66824776 |
| 136 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.66141692 |
| 137 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.65808874 |
| 138 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65729314 |
| 139 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.65162059 |
| 140 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.64069554 |
| 141 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.63491138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 6.73740228 |
| 2 | MP0005671_abnormal_response_to | 5.28678203 |
| 3 | MP0000685_abnormal_immune_system | 3.77934950 |
| 4 | MP0006054_spinal_hemorrhage | 3.69350970 |
| 5 | MP0009333_abnormal_splenocyte_physiolog | 3.31599821 |
| 6 | MP0001873_stomach_inflammation | 3.15365219 |
| 7 | MP0002166_altered_tumor_susceptibility | 3.13830200 |
| 8 | MP0001835_abnormal_antigen_presentation | 3.00800245 |
| 9 | MP0001800_abnormal_humoral_immune | 2.97074179 |
| 10 | MP0002398_abnormal_bone_marrow | 2.87833656 |
| 11 | MP0000703_abnormal_thymus_morphology | 2.83834645 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.74969603 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.74261787 |
| 14 | MP0001819_abnormal_immune_cell | 2.69344209 |
| 15 | MP0000569_abnormal_digit_pigmentation | 2.68174326 |
| 16 | MP0009785_altered_susceptibility_to | 2.55701191 |
| 17 | MP0002723_abnormal_immune_serum | 2.54471775 |
| 18 | MP0002006_tumorigenesis | 2.41501788 |
| 19 | MP0000716_abnormal_immune_system | 2.39052081 |
| 20 | MP0005025_abnormal_response_to | 2.37612570 |
| 21 | MP0002722_abnormal_immune_system | 2.35339669 |
| 22 | MP0002405_respiratory_system_inflammati | 2.34533125 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.33485068 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.28649794 |
| 25 | MP0005387_immune_system_phenotype | 2.26540334 |
| 26 | MP0001790_abnormal_immune_system | 2.26540334 |
| 27 | MP0000689_abnormal_spleen_morphology | 2.20335938 |
| 28 | MP0010352_gastrointestinal_tract_polyps | 2.14840096 |
| 29 | MP0002933_joint_inflammation | 2.12180576 |
| 30 | MP0004147_increased_porphyrin_level | 2.12057551 |
| 31 | MP0006082_CNS_inflammation | 1.91779337 |
| 32 | MP0002429_abnormal_blood_cell | 1.91342188 |
| 33 | MP0002396_abnormal_hematopoietic_system | 1.88663247 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.87393468 |
| 35 | MP0000858_altered_metastatic_potential | 1.84808048 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.78305838 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.77734323 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.77523981 |
| 39 | MP0002419_abnormal_innate_immunity | 1.77521812 |
| 40 | MP0004947_skin_inflammation | 1.77170672 |
| 41 | MP0005623_abnormal_meninges_morphology | 1.73402920 |
| 42 | MP0005645_abnormal_hypothalamus_physiol | 1.68653687 |
| 43 | MP0000372_irregular_coat_pigmentation | 1.68169530 |
| 44 | MP0003436_decreased_susceptibility_to | 1.67736783 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.66676115 |
| 46 | MP0003866_abnormal_defecation | 1.57784560 |
| 47 | MP0009697_abnormal_copulation | 1.45737145 |
| 48 | MP0003724_increased_susceptibility_to | 1.45448368 |
| 49 | MP0004381_abnormal_hair_follicle | 1.39248110 |
| 50 | MP0003448_altered_tumor_morphology | 1.32034131 |
| 51 | MP0005360_urolithiasis | 1.31927119 |
| 52 | MP0003045_fibrosis | 1.30929813 |
| 53 | MP0002877_abnormal_melanocyte_morpholog | 1.28393612 |
| 54 | MP0001529_abnormal_vocalization | 1.24988855 |
| 55 | MP0005174_abnormal_tail_pigmentation | 1.22812724 |
| 56 | MP0001905_abnormal_dopamine_level | 1.22453263 |
| 57 | MP0003646_muscle_fatigue | 1.20222598 |
| 58 | MP0004808_abnormal_hematopoietic_stem | 1.18236422 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.14394011 |
| 60 | MP0000465_gastrointestinal_hemorrhage | 1.13731754 |
| 61 | MP0002009_preneoplasia | 1.10950370 |
| 62 | MP0002019_abnormal_tumor_incidence | 1.09968386 |
| 63 | MP0003787_abnormal_imprinting | 1.07266196 |
| 64 | MP0004957_abnormal_blastocyst_morpholog | 1.04418943 |
| 65 | MP0003303_peritoneal_inflammation | 1.04184765 |
| 66 | MP0002163_abnormal_gland_morphology | 1.02932346 |
| 67 | MP0005379_endocrine/exocrine_gland_phen | 1.00661174 |
| 68 | MP0003075_altered_response_to | 0.95154515 |
| 69 | MP0003252_abnormal_bile_duct | 0.94728577 |
| 70 | MP0008469_abnormal_protein_level | 0.94288977 |
| 71 | MP0001853_heart_inflammation | 0.94119356 |
| 72 | MP0004145_abnormal_muscle_electrophysio | 0.92953235 |
| 73 | MP0002693_abnormal_pancreas_physiology | 0.92439361 |
| 74 | MP0003453_abnormal_keratinocyte_physiol | 0.91475234 |
| 75 | MP0003279_aneurysm | 0.91472331 |
| 76 | MP0005023_abnormal_wound_healing | 0.90445344 |
| 77 | MP0009643_abnormal_urine_homeostasis | 0.88605236 |
| 78 | MP0003880_abnormal_central_pattern | 0.87235772 |
| 79 | MP0005084_abnormal_gallbladder_morpholo | 0.86744415 |
| 80 | MP0001851_eye_inflammation | 0.86657904 |
| 81 | MP0003011_delayed_dark_adaptation | 0.85862143 |
| 82 | MP0006292_abnormal_olfactory_placode | 0.85132020 |
| 83 | MP0003705_abnormal_hypodermis_morpholog | 0.85005450 |
| 84 | MP0005646_abnormal_pituitary_gland | 0.81701507 |
| 85 | MP0009379_abnormal_foot_pigmentation | 0.81186342 |
| 86 | MP0000920_abnormal_myelination | 0.80703072 |
| 87 | MP0001968_abnormal_touch/_nociception | 0.80187406 |
| 88 | MP0005075_abnormal_melanosome_morpholog | 0.79481048 |
| 89 | MP0002132_abnormal_respiratory_system | 0.78921994 |
| 90 | MP0001545_abnormal_hematopoietic_system | 0.76888418 |
| 91 | MP0005397_hematopoietic_system_phenotyp | 0.76888418 |
| 92 | MP0008873_increased_physiological_sensi | 0.75067346 |
| 93 | MP0001533_abnormal_skeleton_physiology | 0.73471934 |
| 94 | MP0003890_abnormal_embryonic-extraembry | 0.73399925 |
| 95 | MP0000015_abnormal_ear_pigmentation | 0.71396473 |
| 96 | MP0002638_abnormal_pupillary_reflex | 0.70924447 |
| 97 | MP0003172_abnormal_lysosome_physiology | 0.70778318 |
| 98 | MP0002837_dystrophic_cardiac_calcinosis | 0.69868722 |
| 99 | MP0002822_catalepsy | 0.69334494 |
| 100 | MP0008057_abnormal_DNA_replication | 0.69264311 |
| 101 | MP0002095_abnormal_skin_pigmentation | 0.69133416 |
| 102 | MP0008872_abnormal_physiological_respon | 0.68419011 |
| 103 | MP0008058_abnormal_DNA_repair | 0.67382937 |
| 104 | MP0004510_myositis | 0.66702456 |
| 105 | MP0001348_abnormal_lacrimal_gland | 0.66244933 |
| 106 | MP0001661_extended_life_span | 0.66136572 |
| 107 | MP0002277_abnormal_respiratory_mucosa | 0.65792853 |
| 108 | MP0003786_premature_aging | 0.64956888 |
| 109 | MP0001188_hyperpigmentation | 0.64493496 |
| 110 | MP0005166_decreased_susceptibility_to | 0.62344781 |
| 111 | MP0001191_abnormal_skin_condition | 0.60595219 |
| 112 | MP0000490_abnormal_crypts_of | 0.60259477 |
| 113 | MP0008961_abnormal_basal_metabolism | 0.58700118 |
| 114 | MP0003091_abnormal_cell_migration | 0.58323215 |
| 115 | MP0003077_abnormal_cell_cycle | 0.58042230 |
| 116 | MP0002998_abnormal_bone_remodeling | 0.57137387 |
| 117 | MP0002653_abnormal_ependyma_morphology | 0.56912777 |
| 118 | MP0001663_abnormal_digestive_system | 0.56813680 |
| 119 | MP0009278_abnormal_bone_marrow | 0.55445843 |
| 120 | MP0003638_abnormal_response/metabolism_ | 0.54611302 |
| 121 | MP0001243_abnormal_dermal_layer | 0.54445964 |
| 122 | MP0009763_increased_sensitivity_to | 0.53991135 |
| 123 | MP0003795_abnormal_bone_structure | 0.53838745 |
| 124 | MP0005408_hypopigmentation | 0.53777770 |
| 125 | MP0005310_abnormal_salivary_gland | 0.52905654 |
| 126 | MP0004883_abnormal_blood_vessel | 0.51597497 |
| 127 | MP0002136_abnormal_kidney_physiology | 0.51096163 |
| 128 | MP0000609_abnormal_liver_physiology | 0.48894993 |
| 129 | MP0009765_abnormal_xenobiotic_induced | 0.48194206 |
| 130 | MP0008569_lethality_at_weaning | 0.47327563 |
| 131 | MP0003693_abnormal_embryo_hatching | 0.46614423 |
| 132 | MP0010094_abnormal_chromosome_stability | 0.45666086 |
| 133 | MP0005076_abnormal_cell_differentiation | 0.45655201 |
| 134 | MP0000477_abnormal_intestine_morphology | 0.44314037 |
| 135 | MP0003959_abnormal_lean_body | 0.44080318 |
| 136 | MP0009764_decreased_sensitivity_to | 0.43613230 |
| 137 | MP0000367_abnormal_coat/_hair | 0.43130339 |
| 138 | MP0000249_abnormal_blood_vessel | 0.42049010 |
| 139 | MP0001764_abnormal_homeostasis | 0.41718839 |
| 140 | MP0004185_abnormal_adipocyte_glucose | 0.40735347 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myositis (HP:0100614) | 7.84878753 |
| 2 | T lymphocytopenia (HP:0005403) | 7.57020259 |
| 3 | Abnormality of T cell number (HP:0011839) | 7.25291088 |
| 4 | Optic neuritis (HP:0100653) | 5.27242624 |
| 5 | Retrobulbar optic neuritis (HP:0100654) | 5.27242624 |
| 6 | Keratoconjunctivitis sicca (HP:0001097) | 5.14722554 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.89779626 |
| 8 | Agammaglobulinemia (HP:0004432) | 4.72753147 |
| 9 | Orchitis (HP:0100796) | 4.65641716 |
| 10 | Keratoconjunctivitis (HP:0001096) | 4.64042070 |
| 11 | Aplastic anemia (HP:0001915) | 4.62370216 |
| 12 | Increased IgM level (HP:0003496) | 4.50694010 |
| 13 | Pustule (HP:0200039) | 4.46272351 |
| 14 | Severe combined immunodeficiency (HP:0004430) | 4.30051177 |
| 15 | Encephalitis (HP:0002383) | 4.27634071 |
| 16 | Abnormality of T cells (HP:0002843) | 4.20005448 |
| 17 | Combined immunodeficiency (HP:0005387) | 4.13839128 |
| 18 | Chronic otitis media (HP:0000389) | 3.88575474 |
| 19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.85368475 |
| 20 | Recurrent abscess formation (HP:0002722) | 3.80027500 |
| 21 | IgG deficiency (HP:0004315) | 3.75876786 |
| 22 | Spontaneous hematomas (HP:0007420) | 3.74730133 |
| 23 | Joint swelling (HP:0001386) | 3.74083173 |
| 24 | Recurrent viral infections (HP:0004429) | 3.61026785 |
| 25 | Eosinophilia (HP:0001880) | 3.56160336 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.53826306 |
| 27 | Obstructive lung disease (HP:0006536) | 3.53826306 |
| 28 | Stomatitis (HP:0010280) | 3.52932871 |
| 29 | Abnormality of eosinophils (HP:0001879) | 3.40595947 |
| 30 | Abnormal platelet volume (HP:0011876) | 3.32238752 |
| 31 | Reduced antithrombin III activity (HP:0001976) | 3.25690362 |
| 32 | Recurrent bacterial skin infections (HP:0005406) | 3.19108525 |
| 33 | Autoimmune thrombocytopenia (HP:0001973) | 3.15682448 |
| 34 | Nasal polyposis (HP:0100582) | 3.14520202 |
| 35 | Thyroiditis (HP:0100646) | 3.13889135 |
| 36 | Leukocytosis (HP:0001974) | 3.12419240 |
| 37 | Spondylolisthesis (HP:0003302) | 3.11609947 |
| 38 | Increased mean platelet volume (HP:0011877) | 3.11475759 |
| 39 | Recurrent cutaneous fungal infections (HP:0011370) | 3.07459884 |
| 40 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.07459884 |
| 41 | Pulmonary embolism (HP:0002204) | 3.06743250 |
| 42 | Abnormality of T cell physiology (HP:0011840) | 3.03551260 |
| 43 | Thrombocytosis (HP:0001894) | 2.99332450 |
| 44 | Arterial thrombosis (HP:0004420) | 2.95772249 |
| 45 | Abnormality of macular pigmentation (HP:0008002) | 2.94157127 |
| 46 | 11 pairs of ribs (HP:0000878) | 2.92983536 |
| 47 | Colon cancer (HP:0003003) | 2.92510036 |
| 48 | Hemoptysis (HP:0002105) | 2.87757034 |
| 49 | Granulocytopenia (HP:0001913) | 2.87426013 |
| 50 | Hypoproteinemia (HP:0003075) | 2.86949681 |
| 51 | Panhypogammaglobulinemia (HP:0003139) | 2.86179774 |
| 52 | Meningitis (HP:0001287) | 2.83536688 |
| 53 | Arterial tortuosity (HP:0005116) | 2.78894104 |
| 54 | Recurrent bronchitis (HP:0002837) | 2.76352963 |
| 55 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.74159882 |
| 56 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.74121035 |
| 57 | Abnormality of the prostate (HP:0008775) | 2.73156631 |
| 58 | Abnormality of B cell number (HP:0010975) | 2.73145850 |
| 59 | B lymphocytopenia (HP:0010976) | 2.73145850 |
| 60 | Mediastinal lymphadenopathy (HP:0100721) | 2.73114015 |
| 61 | Birth length less than 3rd percentile (HP:0003561) | 2.72993003 |
| 62 | Recurrent fungal infections (HP:0002841) | 2.67060853 |
| 63 | Abnormality of the nasal mucosa (HP:0000433) | 2.58695010 |
| 64 | Central scotoma (HP:0000603) | 2.49058514 |
| 65 | Hypergammaglobulinemia (HP:0010702) | 2.47839921 |
| 66 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.47310409 |
| 67 | Dyschromatopsia (HP:0007641) | 2.46083973 |
| 68 | Dry hair (HP:0011359) | 2.45843313 |
| 69 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.45342325 |
| 70 | Autoimmune hemolytic anemia (HP:0001890) | 2.44465787 |
| 71 | Hypoplasia of the thymus (HP:0000778) | 2.44035168 |
| 72 | IgM deficiency (HP:0002850) | 2.41719198 |
| 73 | Vascular tortuosity (HP:0004948) | 2.39930739 |
| 74 | Chest pain (HP:0100749) | 2.38197422 |
| 75 | Long clavicles (HP:0000890) | 2.37124646 |
| 76 | Eczematoid dermatitis (HP:0000976) | 2.36752792 |
| 77 | Aortic aneurysm (HP:0004942) | 2.35863494 |
| 78 | Mitochondrial inheritance (HP:0001427) | 2.35702938 |
| 79 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.33158569 |
| 80 | Pulmonary infiltrates (HP:0002113) | 2.32655096 |
| 81 | Lymphopenia (HP:0001888) | 2.31686419 |
| 82 | Visual hallucinations (HP:0002367) | 2.31120401 |
| 83 | Dicarboxylic aciduria (HP:0003215) | 2.31018867 |
| 84 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.31018867 |
| 85 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.30050923 |
| 86 | Short 4th metacarpal (HP:0010044) | 2.29354976 |
| 87 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.29354976 |
| 88 | Epistaxis (HP:0000421) | 2.28002304 |
| 89 | Striae distensae (HP:0001065) | 2.27489620 |
| 90 | Petechiae (HP:0000967) | 2.27173785 |
| 91 | Inflammation of the large intestine (HP:0002037) | 2.27019180 |
| 92 | Hematochezia (HP:0002573) | 2.26916233 |
| 93 | Abnormal protein glycosylation (HP:0012346) | 2.24007142 |
| 94 | Abnormal glycosylation (HP:0012345) | 2.24007142 |
| 95 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.24007142 |
| 96 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.24007142 |
| 97 | Recurrent sinusitis (HP:0011108) | 2.23902785 |
| 98 | Increased IgE level (HP:0003212) | 2.23468180 |
| 99 | Microcytic anemia (HP:0001935) | 2.20668815 |
| 100 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.20607528 |
| 101 | Abnormality of the pleura (HP:0002103) | 2.18986561 |
| 102 | Nonimmune hydrops fetalis (HP:0001790) | 2.18710887 |
| 103 | Increased intramyocellular lipid droplets (HP:0012240) | 2.18632182 |
| 104 | Gangrene (HP:0100758) | 2.18549897 |
| 105 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.18467334 |
| 106 | Keratitis (HP:0000491) | 2.18238324 |
| 107 | Acute hepatic failure (HP:0006554) | 2.16284018 |
| 108 | Skin rash (HP:0000988) | 2.16191135 |
| 109 | Hepatocellular necrosis (HP:0001404) | 2.16025348 |
| 110 | Thoracolumbar scoliosis (HP:0002944) | 2.15563086 |
| 111 | Biliary tract neoplasm (HP:0100574) | 2.14940622 |
| 112 | Recurrent skin infections (HP:0001581) | 2.14531589 |
| 113 | Lymphoma (HP:0002665) | 2.14157963 |
| 114 | Vasculitis (HP:0002633) | 2.13810260 |
| 115 | Neoplasm of the small intestine (HP:0100833) | 2.13267731 |
| 116 | Toxemia of pregnancy (HP:0100603) | 2.12598369 |
| 117 | Gastrointestinal inflammation (HP:0004386) | 2.12502954 |
| 118 | Prolonged bleeding time (HP:0003010) | 2.12134722 |
| 119 | Aortic dissection (HP:0002647) | 2.11432073 |
| 120 | Chronic sinusitis (HP:0011109) | 2.10616338 |
| 121 | Abnormal hair whorl (HP:0010721) | 2.07070608 |
| 122 | Gastrointestinal infarctions (HP:0005244) | 2.05856676 |
| 123 | Abnormality of macrophages (HP:0004311) | 2.05562744 |
| 124 | Aseptic necrosis (HP:0010885) | 2.02935246 |
| 125 | Rectal prolapse (HP:0002035) | 2.02623660 |
| 126 | Abnormality of the fingertips (HP:0001211) | 2.01305704 |
| 127 | Abnormality of the columella (HP:0009929) | 2.01060340 |
| 128 | J-shaped sella turcica (HP:0002680) | 2.00108580 |
| 129 | Recurrent otitis media (HP:0000403) | 2.00076484 |
| 130 | 3-Methylglutaconic aciduria (HP:0003535) | 1.99235714 |
| 131 | Focal motor seizures (HP:0011153) | 1.98713482 |
| 132 | Thoracic kyphosis (HP:0002942) | 1.98345298 |
| 133 | Chronic diarrhea (HP:0002028) | 1.95165677 |
| 134 | Severe visual impairment (HP:0001141) | 1.94349566 |
| 135 | Type I transferrin isoform profile (HP:0003642) | 1.94206519 |
| 136 | Sepsis (HP:0100806) | 1.93620277 |
| 137 | Abolished electroretinogram (ERG) (HP:0000550) | 1.93135366 |
| 138 | Mesomelia (HP:0003027) | 1.90996970 |
| 139 | Glomerulopathy (HP:0100820) | 1.90838421 |
| 140 | Papilloma (HP:0012740) | 1.90659810 |
| 141 | Verrucae (HP:0200043) | 1.90659810 |
| 142 | Fatigue (HP:0012378) | 1.90459505 |
| 143 | Palpebral edema (HP:0100540) | 1.89788870 |
| 144 | Bronchitis (HP:0012387) | 1.89684829 |
| 145 | Thrombophlebitis (HP:0004418) | 1.87580320 |
| 146 | Cellular immunodeficiency (HP:0005374) | 1.87233598 |
| 147 | Urticaria (HP:0001025) | 1.86519064 |
| 148 | Broad face (HP:0000283) | 1.85650131 |
| 149 | Cerebral palsy (HP:0100021) | 1.85007998 |
| 150 | Abnormality of the lumbar spine (HP:0100712) | 1.84326068 |
| 151 | Abnormal foot bone ossification (HP:0010675) | 1.83481870 |
| 152 | Hepatic necrosis (HP:0002605) | 1.83288466 |
| 153 | Abnormality of the pericardium (HP:0001697) | 1.82055046 |
| 154 | Increased muscle lipid content (HP:0009058) | 1.80031175 |
| 155 | Abnormality of the thymus (HP:0000777) | 1.78727763 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 5.75835912 |
| 2 | MAP4K1 | 4.69214168 |
| 3 | CDK8 | 4.28679469 |
| 4 | ITK | 3.73638772 |
| 5 | VRK2 | 3.59024058 |
| 6 | NLK | 3.55731931 |
| 7 | CLK1 | 3.02449178 |
| 8 | MELK | 3.01669483 |
| 9 | ZAP70 | 2.89966995 |
| 10 | BCKDK | 2.83685982 |
| 11 | MAP3K14 | 2.78872001 |
| 12 | MAP2K6 | 2.78427860 |
| 13 | ZAK | 2.75520577 |
| 14 | NME2 | 2.66137160 |
| 15 | MST4 | 2.49232358 |
| 16 | JAK3 | 2.38770943 |
| 17 | SCYL2 | 2.36783257 |
| 18 | TESK1 | 2.31823633 |
| 19 | VRK1 | 2.29879635 |
| 20 | PRPF4B | 2.21738748 |
| 21 | STK10 | 2.19227237 |
| 22 | ACVR1B | 2.01797792 |
| 23 | TLK1 | 1.95033597 |
| 24 | LCK | 1.86911850 |
| 25 | GRK6 | 1.85992290 |
| 26 | GRK7 | 1.81700153 |
| 27 | PRKCH | 1.80438755 |
| 28 | ADRBK2 | 1.78443393 |
| 29 | MAP3K7 | 1.75391558 |
| 30 | FGFR4 | 1.73761235 |
| 31 | TAOK3 | 1.69642274 |
| 32 | DAPK1 | 1.62144274 |
| 33 | BLK | 1.57109612 |
| 34 | CSK | 1.54350152 |
| 35 | LIMK1 | 1.53889725 |
| 36 | TYK2 | 1.51410708 |
| 37 | CDK9 | 1.50586098 |
| 38 | SIK3 | 1.48305084 |
| 39 | EPHA3 | 1.45772771 |
| 40 | SYK | 1.45296170 |
| 41 | IKBKE | 1.37917769 |
| 42 | DAPK2 | 1.30851991 |
| 43 | HCK | 1.21828913 |
| 44 | CDK4 | 1.20280707 |
| 45 | MAP4K2 | 1.19154211 |
| 46 | CDK19 | 1.18876389 |
| 47 | TEC | 1.17682342 |
| 48 | NUAK1 | 1.15890571 |
| 49 | FGFR3 | 1.15324036 |
| 50 | EIF2AK3 | 1.12849422 |
| 51 | MARK3 | 1.09947397 |
| 52 | JAK1 | 1.05462767 |
| 53 | RPS6KA5 | 1.03119292 |
| 54 | BTK | 1.02047831 |
| 55 | MATK | 0.99653058 |
| 56 | TBK1 | 0.97564535 |
| 57 | BRSK1 | 0.96116993 |
| 58 | BRSK2 | 0.92136761 |
| 59 | LRRK2 | 0.91250949 |
| 60 | GRK1 | 0.85918407 |
| 61 | MAP3K11 | 0.85703742 |
| 62 | PRKCQ | 0.84321642 |
| 63 | PIM1 | 0.80016885 |
| 64 | PIM2 | 0.77822249 |
| 65 | PIK3CG | 0.77092406 |
| 66 | MAP3K5 | 0.76640021 |
| 67 | PKN2 | 0.74850979 |
| 68 | DAPK3 | 0.74385359 |
| 69 | MAP3K13 | 0.73503069 |
| 70 | TRPM7 | 0.70381989 |
| 71 | FLT3 | 0.68612149 |
| 72 | TAF1 | 0.68447231 |
| 73 | PDK2 | 0.66297312 |
| 74 | GRK5 | 0.64585927 |
| 75 | KDR | 0.64448878 |
| 76 | IRAK2 | 0.64389196 |
| 77 | SIK2 | 0.63927978 |
| 78 | FES | 0.63925683 |
| 79 | EEF2K | 0.62850317 |
| 80 | MAP3K12 | 0.61936260 |
| 81 | TIE1 | 0.60942620 |
| 82 | BMPR2 | 0.60564394 |
| 83 | LYN | 0.60166756 |
| 84 | KSR1 | 0.58145993 |
| 85 | MAPKAPK5 | 0.58055419 |
| 86 | WEE1 | 0.54727800 |
| 87 | PDGFRB | 0.53195390 |
| 88 | JAK2 | 0.50704470 |
| 89 | FGFR2 | 0.48672496 |
| 90 | ERN1 | 0.47987215 |
| 91 | PRKG2 | 0.47683684 |
| 92 | SGK3 | 0.45540526 |
| 93 | MAP3K10 | 0.44335492 |
| 94 | ROCK1 | 0.43589877 |
| 95 | RAF1 | 0.42422158 |
| 96 | SIK1 | 0.42214343 |
| 97 | MARK2 | 0.41012998 |
| 98 | IKBKB | 0.40972123 |
| 99 | AURKA | 0.40035755 |
| 100 | BCR | 0.39838645 |
| 101 | RPS6KC1 | 0.37919494 |
| 102 | RPS6KL1 | 0.37919494 |
| 103 | TNK2 | 0.37476298 |
| 104 | SMG1 | 0.37098298 |
| 105 | MAPK7 | 0.36458738 |
| 106 | FYN | 0.35935524 |
| 107 | DYRK2 | 0.35882433 |
| 108 | ALK | 0.35175494 |
| 109 | RPS6KA6 | 0.34729664 |
| 110 | STK11 | 0.33793025 |
| 111 | ATR | 0.33379259 |
| 112 | PINK1 | 0.32110346 |
| 113 | CSF1R | 0.31574206 |
| 114 | IGF1R | 0.31448182 |
| 115 | MYLK | 0.31427041 |
| 116 | INSR | 0.30603553 |
| 117 | PAK3 | 0.30192677 |
| 118 | RIPK4 | 0.29857450 |
| 119 | INSRR | 0.28751651 |
| 120 | CDC7 | 0.28324028 |
| 121 | KIT | 0.27258433 |
| 122 | PRKCA | 0.26590079 |
| 123 | PAK4 | 0.26099042 |
| 124 | TYRO3 | 0.25956222 |
| 125 | PASK | 0.25269096 |
| 126 | MAPKAPK3 | 0.24714943 |
| 127 | MAPK11 | 0.24595337 |
| 128 | ADRBK1 | 0.23580987 |
| 129 | CSNK1G1 | 0.23459762 |
| 130 | CSNK1G3 | 0.23380790 |
| 131 | RPS6KA4 | 0.23307998 |
| 132 | EPHB1 | 0.23305325 |
| 133 | CCNB1 | 0.22221958 |
| 134 | TTN | 0.22203625 |
| 135 | IRAK4 | 0.21615367 |
| 136 | TGFBR2 | 0.21269323 |
| 137 | PRKCD | 0.20717277 |
| 138 | PDK1 | 0.20431644 |
| 139 | PAK1 | 0.20068370 |
| 140 | MAPK13 | 0.19659024 |
| 141 | CDK6 | 0.18818104 |
| 142 | MAP2K2 | 0.18439571 |
| 143 | MAPK3 | 0.18202173 |
| 144 | ABL1 | 0.17825027 |
| 145 | HIPK2 | 0.17809714 |
| 146 | KSR2 | 0.17471386 |
| 147 | TESK2 | 0.17233886 |
| 148 | STK4 | 0.16494695 |
| 149 | TRIB3 | 0.15055063 |
| 150 | FGFR1 | 0.14750411 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 5.70099398 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.43248080 |
| 3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.30964221 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.84544752 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.75630260 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.22171017 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 3.03146566 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.79573202 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.62160522 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.47126416 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.15962248 |
| 12 | Viral myocarditis_Homo sapiens_hsa05416 | 2.12069471 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.01128855 |
| 14 | Parkinsons disease_Homo sapiens_hsa05012 | 1.96069044 |
| 15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.89913292 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.78196787 |
| 17 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.69307036 |
| 18 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.68978927 |
| 19 | Colorectal cancer_Homo sapiens_hsa05210 | 1.66201829 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.61299860 |
| 21 | Ribosome_Homo sapiens_hsa03010 | 1.53399955 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.50393925 |
| 23 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.40648002 |
| 24 | Hepatitis B_Homo sapiens_hsa05161 | 1.34371019 |
| 25 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.30656366 |
| 26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27261963 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.26585831 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24034099 |
| 29 | Homologous recombination_Homo sapiens_hsa03440 | 1.16058942 |
| 30 | Alzheimers disease_Homo sapiens_hsa05010 | 1.14281183 |
| 31 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.13511571 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.12101130 |
| 33 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.10039419 |
| 34 | Proteasome_Homo sapiens_hsa03050 | 1.07649820 |
| 35 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.07628774 |
| 36 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.06754960 |
| 37 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.05937699 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.01587499 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.98657247 |
| 40 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.97205233 |
| 41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.96943079 |
| 42 | Huntingtons disease_Homo sapiens_hsa05016 | 0.94192760 |
| 43 | HTLV-I infection_Homo sapiens_hsa05166 | 0.93574448 |
| 44 | Base excision repair_Homo sapiens_hsa03410 | 0.91840242 |
| 45 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.91754773 |
| 46 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.90207580 |
| 47 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.88723257 |
| 48 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.87963520 |
| 49 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.87135296 |
| 50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86770274 |
| 51 | Phototransduction_Homo sapiens_hsa04744 | 0.84506463 |
| 52 | Platelet activation_Homo sapiens_hsa04611 | 0.83219172 |
| 53 | Spliceosome_Homo sapiens_hsa03040 | 0.82844515 |
| 54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.80100178 |
| 55 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77195339 |
| 56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74674095 |
| 57 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.73136230 |
| 58 | Adherens junction_Homo sapiens_hsa04520 | 0.72261483 |
| 59 | RNA polymerase_Homo sapiens_hsa03020 | 0.71692975 |
| 60 | Influenza A_Homo sapiens_hsa05164 | 0.71630054 |
| 61 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.68950783 |
| 62 | Protein export_Homo sapiens_hsa03060 | 0.66511567 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.65551010 |
| 64 | Shigellosis_Homo sapiens_hsa05131 | 0.64949883 |
| 65 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.62846694 |
| 66 | DNA replication_Homo sapiens_hsa03030 | 0.61675655 |
| 67 | Prion diseases_Homo sapiens_hsa05020 | 0.59082958 |
| 68 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58278457 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57556077 |
| 70 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.56661877 |
| 71 | Mismatch repair_Homo sapiens_hsa03430 | 0.56337512 |
| 72 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.55924835 |
| 73 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.54328311 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.51294854 |
| 75 | Apoptosis_Homo sapiens_hsa04210 | 0.50613927 |
| 76 | Pertussis_Homo sapiens_hsa05133 | 0.50424824 |
| 77 | Retinol metabolism_Homo sapiens_hsa00830 | 0.49948717 |
| 78 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.49581478 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.49174821 |
| 80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48725826 |
| 81 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.48602867 |
| 82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48522335 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47831792 |
| 84 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.46375063 |
| 85 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.44832170 |
| 86 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.44014014 |
| 87 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.42626055 |
| 88 | Salmonella infection_Homo sapiens_hsa05132 | 0.42495265 |
| 89 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.41252176 |
| 90 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41047773 |
| 91 | Basal transcription factors_Homo sapiens_hsa03022 | 0.40891324 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40438923 |
| 93 | Cell cycle_Homo sapiens_hsa04110 | 0.40287002 |
| 94 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.39903505 |
| 95 | Long-term potentiation_Homo sapiens_hsa04720 | 0.39805758 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39467174 |
| 97 | Malaria_Homo sapiens_hsa05144 | 0.39212362 |
| 98 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.37997184 |
| 99 | Purine metabolism_Homo sapiens_hsa00230 | 0.36866833 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36014746 |
| 101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35953688 |
| 102 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.34327766 |
| 103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.33880462 |
| 104 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33858811 |
| 105 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.33256560 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | 0.32461984 |
| 107 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.32114521 |
| 108 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.31448269 |
| 109 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.31347913 |
| 110 | Thyroid cancer_Homo sapiens_hsa05216 | 0.30881598 |
| 111 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.30735930 |
| 112 | Legionellosis_Homo sapiens_hsa05134 | 0.30178967 |
| 113 | Olfactory transduction_Homo sapiens_hsa04740 | 0.29884079 |
| 114 | Tuberculosis_Homo sapiens_hsa05152 | 0.29765491 |
| 115 | RNA degradation_Homo sapiens_hsa03018 | 0.28630915 |
| 116 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25161105 |
| 117 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23633849 |
| 118 | Prostate cancer_Homo sapiens_hsa05215 | 0.23526136 |
| 119 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.23424376 |
| 120 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.23331704 |
| 121 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.23308905 |
| 122 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.23016569 |
| 123 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.22078120 |
| 124 | Endometrial cancer_Homo sapiens_hsa05213 | 0.22062101 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.21211418 |
| 126 | Asthma_Homo sapiens_hsa05310 | 0.20291328 |
| 127 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.19922575 |
| 128 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.15812883 |
| 129 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.15421694 |
| 130 | Peroxisome_Homo sapiens_hsa04146 | 0.14819887 |
| 131 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.14536288 |
| 132 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.14374945 |
| 133 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.14158208 |
| 134 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.13940620 |
| 135 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.13004373 |
| 136 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.11307459 |
| 137 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.10757330 |
| 138 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.10453938 |
| 139 | Salivary secretion_Homo sapiens_hsa04970 | 0.09009819 |
| 140 | Renin secretion_Homo sapiens_hsa04924 | 0.08092095 |
| 141 | Focal adhesion_Homo sapiens_hsa04510 | 0.05883227 |

